TrialJournal of pharmacokinetics and pharmacodynamics2026

Early exposure-response modeling of an interferon-beta monoclonal antibody (dazukibart) in adults with dermatomyositis.

John P Prybylski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.